Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Red cell enzymes.

Josef T Prchal1, Xylina T Gregg

  • 1Baylor College of Medicine, One Baylor Plaza, 802E, Houston, Texas 77030, USA. jprchal@bcm.tmc.edu

Hematology. American Society of Hematology. Education Program
|November 24, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selinexor plus ruxolitinib in JAK inhibitor-naïve patients with myelofibrosis: a multicenter, open-label, phase 1 study.

Blood advances·2026
Same author

Why JAK2-mutated neutrophils deserve to be on center stage in polycythemia vera.

Annals of hematology·2026
Same author

Ropeginterferon alfa-2b has minimal transplacental passage and breastmilk secretion in pregnant patients with MPN.

Blood advances·2026
Same author

Autosomal Dominant Erythrocytosis Caused by Non-Renal Erythropoietin (EPO) Due to EPO c.-136 G>A Germline Mutation.

American journal of hematology·2026
Same author

Do Andean Aymara High-Altitude-Enriched Genetic Variants Protect Europeans Against Acute Mountain Sickness?

Acta physiologica (Oxford, England)·2026
Same author

VHL, transferrin, and erythropoietin in the regulation of hepcidin.

HemaSphere·2025
Same journal

Nze C, Flowers CR. Barriers to accessing cellular therapy for patients receiving care in community practices. Hematology Am Soc Hematol Educ Program. 2023;2023(1):382-385.

Hematology. American Society of Hematology. Education Program·2025
Same journal

CAR T-cell therapy and bispecific antibodies in the management of multiple myeloma.

Hematology. American Society of Hematology. Education Program·2025
Same journal

Emerging immunotherapy advances for non-Hodgkin lymphomas: engaging T cells in the fight.

Hematology. American Society of Hematology. Education Program·2025
Same journal

Anticoagulants in hematologic malignancies: what is the data?

Hematology. American Society of Hematology. Education Program·2025
Same journal

Diagnosis and management of cold agglutinin disease.

Hematology. American Society of Hematology. Education Program·2025
Same journal

What to know about rare B-cell malignancies in 2025.

Hematology. American Society of Hematology. Education Program·2025
See all related articles

Red cell enzyme deficiencies, like glucose-6-phosphate dehydrogenase (G6PD) deficiency, can cause various health issues. Some G6PD mutations offer malaria protection, influencing their prevalence.

Area of Science:

  • Biochemistry
  • Genetics
  • Hematology

Background:

  • Red blood cell enzyme deficiencies present diverse clinical phenotypes.
  • Mutations can lead to conditions such as hemolytic anemia, methemoglobinemia, and neurological issues.
  • Some enzyme deficiencies, like G6PD, are prevalent due to evolutionary advantages, such as malaria resistance.

Purpose of the Study:

  • To review common red cell enzyme deficiencies.
  • To discuss glucose-6-phosphate dehydrogenase (G6PD), pyruvate kinase, 5' nucleotidase, and cytochrome b5 reductase deficiencies.
  • To highlight limitations in current diagnostic screening tests and explore non-enzymatic functions of glycolytic enzymes.

Main Methods:

  • Literature review focusing on red cell enzyme deficiencies.

Related Experiment Videos

  • Analysis of genetic mutations and their associated phenotypes.
  • Examination of diagnostic screening methods and emerging research.

    • Main Results:

    • Mutations in red cell enzymes result in a spectrum of diseases.
    • Common G6PD variants are widespread, likely due to conferring protection against malaria.
    • Existing screening tests have limitations for detecting these disorders.

    Conclusions:

    • Red cell enzyme deficiencies are clinically significant genetic disorders.
    • The prevalence of certain enzyme deficiencies is influenced by selective pressures like malaria.
    • Further research is needed to improve diagnostic accuracy and understand the full functional spectrum of these enzymes.